|
PLEKHM3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.546500E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.979800E-01 |
| Normal-vs-Stage2 |
1.248040E-01 |
| Normal-vs-Stage3 |
1.390410E-02 |
| Normal-vs-Stage4 |
8.430000E-04 |
| Stage1-vs-Stage2 |
9.070100E-02 |
| Stage1-vs-Stage3 |
8.056100E-03 |
| Stage1-vs-Stage4 |
6.176500E-04 |
| Stage2-vs-Stage3 |
8.118800E-01 |
| Stage2-vs-Stage4 |
3.356200E-01 |
| Stage3-vs-Stage4 |
3.723000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.534300E-02 |
| Normal-vs-AfricanAmerican |
1.404370E-01 |
| Normal-vs-Asian |
5.595400E-01 |
| Caucasian-vs-AfricanAmerican |
7.870400E-01 |
| Caucasian-vs-Asian |
8.360400E-01 |
| AfricanAmerican-vs-Asian |
9.091400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.856300E-02 |
| Normal-vs-Female |
1.118550E-01 |
| Male-vs-Female |
9.035800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.059700E-03 |
| Normal-vs-Age(41-60Yrs) |
3.485600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.562200E-02 |
| Normal-vs-Age(81-100Yrs) |
4.257000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.615900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.438400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.887600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.967790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.984000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.776800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.464200E-02 |
| Normal-vs-Grade 2 |
9.702800E-01 |
| Normal-vs-Grade 3 |
1.361630E-02 |
| Normal-vs-Grade 4 |
2.588400E-04 |
| Grade 1-vs-Grade 2 |
3.713800E-02 |
| Grade 1-vs-Grade 3 |
1.019850E-02 |
| Grade 1-vs-Grade 4 |
5.93620000000072E-05 |
| Grade 2-vs-Grade 3 |
1.197830E-02 |
| Grade 2-vs-Grade 4 |
6.625100E-04 |
| Grade 3-vs-Grade 4 |
3.664200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.322400E-01 |
| Normal-vs-ccB subtype |
1.057340E-03 |
| ccA subtype-vs-ccB subtype |
2.21799999999828E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.918500E-02 |
| Normal-vs-N1 |
3.221300E-03 |
| N0-vs-N1 |
1.664360E-01 |
|
|
